Management options for pediatric venous thromboembolic disease: Beyond anticoagulation with endovascular therapies.
Review published in Thrombosis research (2024)
Abstract
Venous thromboembolism (VTE) in pediatric patients is an uncommon but serious diagnosis that has an array of therapeutic options and challenges. An assessment of the existing literature on management of pediatric patients with VTE was conducted. The interventions reviewed include anticoagulation, thrombolysis, thrombectomy, inferior vena cava (IVC) filters, and venous stenting. For each intervention, a discussion of mechanism of action, indications, contraindications, and potential complications was performed. While anticoagulants are considered the first-line pediatric VTE treatment, many drugs remain investigational in this patient population and treatment recommendations are extrapolated from adult practice. Thrombolysis may be indicated in cases of acute thrombosis requiring more rapid clot resolution but presents a greater bleeding risk than anticoagulation. Similarly, thrombectomy also provides rapid clot resolution and offers a larger therapeutic window and usage in more mature thrombi than thrombolysis. In select patient groups, IVC filters may be indicated in the prevention of PE but present with inherent thrombogenicity and risk of migration. The data regarding pediatric VTE treatment options, monitoring, and long term outcomes is limited compared to the adult population. The relatively few clinical trials including pediatric patients have a relatively small sample size and are heterogenous with regards to predisposing factors that further exacerbate generalizability. Additional research is needed to help construct and evaluate a robust treatment algorithm for pediatric patients with VTE.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Zusammenfassung
Venous thromboembolism (VTE) in pediatric patients is an uncommon but serious diagnosis that has an array of therapeutic options and challenges. An assessment of the existing literature on management of pediatric patients with VTE was conducted.
Warum dies für die Hirudotherapie relevant ist
Dieser Review bewertet die bestehende Literatur zum Management der pädiatrischen venösen thromboembolischen Erkrankung, einschließlich Antikoagulation, Thrombolyse, Thrombektomie, Vena-cava-inferior-Filtern und venösem Stenting, mit Diskussion der Mechanismen, Indikationen, Kontraindikationen und Komplikationen jedes Verfahrens. Die Autoren weisen darauf hin, dass Antikoagulanzien zwar die Erstlinientherapie darstellen, viele Medikamente in pädiatrischen Populationen jedoch weiterhin untersucht werden und Daten zu Monitoring und Langzeitergebnissen begrenzt sind. Das Abstract enthält keine Erwähnung von Blutegeln, Hirudotherapie, aus Blutegeln gewonnenen Verbindungen oder dem Blutegel-Sekretom. Es besteht keine vertretbare Verbindung zum ASH-Gebiet, da der Review ausschließlich konventionelle endovaskuläre Therapien und pharmazeutische Wirkstoffe evaluiert.
Zitation
Management options for pediatric venous thromboembolic disease: Beyond anticoagulation with endovascular therapies.
Mitta et al. · Thrombosis research, 2024
Verwandter klinischer Kontext
Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist
Zur ASH-Bibliothek hinzugefügt: May 28, 2026 · Letzte Aktualisierung der Website: 18. Juni 2026